29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
15 °P sammeln
  • Broschiertes Buch

Diabetes Mellitus is a global health challenge, projected to affect 366 million people by 2030. Diabetic nephropathy, a major microvascular complication, not only leads to chronic kidney disease and end-stage renal failure but also increases cardiovascular risk, disability, and overall mortality, thereby severely impairing quality of life. Thus, an integrated approach combining optimal glycemic control, blood pressure regulation, renoprotective therapy, and lifestyle modification remains the cornerstone of preventing progression to end-stage renal disease in diabetic nephropathy.

Produktbeschreibung
Diabetes Mellitus is a global health challenge, projected to affect 366 million people by 2030. Diabetic nephropathy, a major microvascular complication, not only leads to chronic kidney disease and end-stage renal failure but also increases cardiovascular risk, disability, and overall mortality, thereby severely impairing quality of life. Thus, an integrated approach combining optimal glycemic control, blood pressure regulation, renoprotective therapy, and lifestyle modification remains the cornerstone of preventing progression to end-stage renal disease in diabetic nephropathy.
Autorenporträt
Dr Swati Prasad Panbude, MBBS, MD Biochemistry (Gold Medalist), Fellowship in Diabetes Mellitus. Associate Professor, Datta Meghe Medical College, Nagpur. Active contribution to scientific research through publications in both national and international journals.